Allworth Financial’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
Allworth Financial's MLYS Position: Q3 2026 in Review
Allworth Financial increased its Mineralys Therapeutics (MLYS) stake by 298% in Q3 2026, buying an estimated $8.19K and bringing the position to 402 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4060.
Allworth Financial first reported a position in MLYS in Q2 2024 and has held it in 10 quarters since. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- Allworth Financial held 402 shares of Mineralys Therapeutics worth $10.1K as of Q3 2026.
- Allworth Financial bought 301 Mineralys Therapeutics shares in Q3 2026, an estimated $8.19K.
- Mineralys Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4060 holding.
- Allworth Financial first reported a position in Mineralys Therapeutics in Q2 2024 and has held it in 10 quarters since.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.